Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Randox Launches ELISA

Published: Tuesday, April 23, 2013
Last Updated: Tuesday, April 23, 2013
Bookmark and Share
Detection of new generation Synthetic Cannabinoids (Spice) drugs UR-144 and XLR-11.

Randox Toxicology has developed an ELISA targeting UR-144, XLR-11 and additional Synthetic Cannabinoid compounds which are commonly found in new ‘Spice’ and ‘K2’ blends.

These emerging compounds have been rapidly introduced to the designer drug market in response to legislation banning previously identified compounds.

As a result, other screening methods have since become out-dated, creating a difficult task for toxicologists who require a new way to detect the novel drugs.

Together with Randox Toxicology’s JWH/ AM2201 Synthetic Cannabinoids ELISA, the new UR-144/ XLR-11 ELISA provides a comprehensive solution for the rapid detection of over 55 current Synthetic Cannabinoids in urine, blood and oral fluid.

UR-144 and XLR-11 are chemically different structures to earlier generations of Synthetic Cannabinoids such as JWH-018, JWH-073 or AM-2201, and therefore are not detected by any other immunoassay product on the market.

The last decade has seen a proliferation in ‘designer drugs,’ developed by changing the molecular structure of one or more existing drugs to create a new substance.

Last week the United States Drug Enforcement Administration announced plans to schedule UR-144, XLR-11, and AKB48 which are often seen in falsely marketed “herbal incense” products. They are sold under various brand names, online, in head shops and even gas stations.

Despite many uncertainties, the use of these products is widespread and their detection is crucial in order to eradicate their use and damaging side effects.

The Randox Toxicology Synthetic Cannabinoids ELISA package delivers the most comprehensive cross reactivity profile on the market; allowing toxicologists to ensure that samples positive with new drug blends are not concealed.

A batch of samples can be economically processed with the 96 test kits, eliminating negative samples from further analysis.

Randox Toxicology is at the forefront of developing immunoassay solutions in response to the widespread designer drug movement. In addition to the new Synthetic Cannabinoids ELISA, Randox Toxicology offers a range of leading designer drug solutions including ELISAs for the detection of “Bath Salts” (Mephedrone, Methcathinone, MDPV) and a comprehensive 11-plex biochip array which can detect up to 110 novel drug compounds.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Developing Drug Resistance may be a Matter of Diversity for Tuberculosis
Researchers have probed the bacteria that causes tuberculosis, Mycobacterium tuberculosis, to learn more about how individual bacterial cells change and adapt while in the human body.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
Essential Component of Antiviral Defense Identified
Infectious disease researchers at the University of Georgia have identified a signaling protein critical for host defense against influenza infection.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Is Allergy the Price We Pay for Our Immunity to Parasites?
New findings help demonstrate the evolutionary basis for allergy.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos